期刊文献+

经尿道钬激光切除术治疗非肌层浸润性膀胱癌患者的安全性及预后观察

Safety and Prognosis of Transurethral Holmium Laser Resection for Non-muscular Invasive Bladder Cancer
下载PDF
导出
摘要 目的:探讨经尿道钬激光切除术(HOLBT)在非肌层浸润性膀胱癌(NMIBC)患者中的应用效果。方法:选取笔者所在医院2017年4月-2018年7月收治的NMIBC患者76例,依照治疗方案不同分为两组,各38例,经尿道双极等离子电切术(TUPKRP)组采用TUPKRP术,HOLBT组采用HOLBT。比较两组手术时间、尿管留置时间、住院时间、术后并发症发生率,术后1年肿瘤预后标志物(Ki-67蛋白、P53蛋白)表达情况,术前、术后1年生活质量核心量表(QLQ-C30)评分。结果:HOLBT组尿管留置时间、手术时间、住院时间均短于TUPKRP组,差异均有统计学意义(P<0.05);HOLBT组术后膀胱穿孔、闭孔神经反射并发症发生率(0、0)均低于TUPKRP组(15.79%、23.68%),HOLBT组术后1年Ki-67蛋白、P53蛋白阴性率(81.08%、83.78%)均高于TUPKRP组(54.05%、56.76%),差异均有统计学意义(P<0.05);HOLBT组术后1年QLQ-C30评分低于TUPKRP组,差异有统计学意义(P<0.05)。结论:HOLBT术治疗NMIBC患者,可缩短手术时间,促进恢复,降低术后并发症发生率,改善预后,提高生活质量。 Objective:To investigate the effect of transurethral holmium laser resection(HOLBT)in patients with non-muscular invasive bladder cancer(NMIBC).Method:A total of 76 NMIBC patients in our hospital from April 2017 to July 2018 were selected,according to different treatment regiments,the patients were divided into two groups,38 cases each.TUPKRP was used in the transurethral bipolar plasma electrotomy(TUPKRP)group,and HOLBT was used in the HOLBT group.The operative time,urinary indwelling time,length of hospital stay,incidence of postoperative complications,expression of tumor prognostic markers(Ki-67 protein and P53 protein)at 1 year after surgery,and QLQ-C30 scores before and 1 year after surgery were compared between the two groups.Result:The catheter indwelling time,operation time and hospital stay time in the HOLBT group were shorter than those in the TUPKRP group,the differences were statistically significant(P<0.05).The incidence of postoperative bladder perforation and obturator nerve reflex complications in the HOLBT group(0,0)were lower than those in TUPKRP group(15.79%,23.68%),and the negative rates of Ki-67 protein and P53 protein in the HOLBT group(81.08%,83.78%)were higher than those in the TUPKRP group(54.05%,56.76%)1 year after surgery,the differences were statistically significant(P<0.05).The QLQ-C30 score in the HOLBT group 1 year after operation was lower than that in the TUPKRP group,the difference was statistically significant(P<0.05).Conclusion:HOLBT for NMIBC patients can shorten the operation time,promote the recovery,reduce the incidence of postoperative complications,improve the prognosis and improve the quality of life.
作者 龙赟 叶剑锋 LONG Yun;YE Jianfeng(Daye People’s Hospital,Daye 435100,China;不详)
机构地区 大冶市人民医院
出处 《中外医学研究》 2020年第26期161-163,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 经尿道钬激光切除术 经尿道双极等离子电切术 非肌层浸润性膀胱癌 安全性 预后 Transurethral holmium laser resection Transurethral bipolar plasma electrotomy Non-muscular invasive bladder cancer Security Prognosis
  • 相关文献

参考文献12

二级参考文献91

  • 1沈肖曹,杜传军,史时芳,陈继民,经宵.经尿道钬激光切除与经尿道电切治疗浅表性膀胱肿瘤的疗效比较[J].中华泌尿外科杂志,2005,26(1):30-32. 被引量:42
  • 2Ofude M, Kitagawa Y, Yaegashi H, et al. Selection of adjuvaot intravesical therapies using the Europeao Orgaoization for Research aod Treatment of Caocer scoring system in patients at intermediate risk of non - muscle - invasive bladder caocer [J] . J Cancer Res Clin Oncol,2014,10, [Epub ahead of print].
  • 3Wood DP . Prospective Raodomized Trial of Hexylaminolevulinate Photodynamic - Assisted Traosurethral Resection of Bladder Tumour (TURBT) plus Single - Shot Intravesical Mitomycin C vs Conventional White - Light TURBT plus Mitomycin C in Newly Presenting Non - Muscle - Invasive Bladder Caocer [J]. J Urol, 2014,192(3) :723.
  • 4Hermann TR, Liatsikos EN, Nagele U, et al. EAU guidelines on laser technologies[J]. Eur Urol,2012, 61(4) :783 -795.
  • 5Jacobs BL, Lee CT, Montie JE. Bladder caocer in 2010: how far have we come[J]. CAl Clin, 2010, 60(5):244 -272.
  • 6Engilbertsson H, Aaltonen KE, Bjmsson S, et al. TURBT Can Cause Seeding of Caocer Cells into the Bloodstream [J].2014,1. [Epub ahead of print] .
  • 7Kramer MW, Wolters M, Cash H, et al. Current evidence of transurethral Ho , YAG aod Tm , YAG treatment of bladder cancer: update 2014 [J]. 2014 ,17. [Epub ahead of print].
  • 8Ohsugi H, Kitamura Y, Manabe Y, et al. Efficacy of prophylactic intravesical mitomycin C in patients with non - muscle - invasive bladder cancer[J]. Hinyokika Kiyo, 2014,60(8) :375 -379.
  • 9Nishiyama N, Kitamura H, Hotta H, et al. Construction of Predictive Models for Cancer - specific Survival of Patients with Non - muscle Invasive Bladder Caocer Treated with Bacillus Calmette - Guerin: Results from a Multicenter Retrospective Study. Jpn J Clin Oncol,2014,19. [Epub ahead of print].
  • 10Reek C, Bloch M. Intravesical Therapy for Non - muscle Invasive Bladder Tumours with Doxorubicin. An Update of the Standard of Care in Urological Practices[J]. Aktuelle Urol,2014,45 (5) :377 -380.

共引文献209

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部